SILO PHARMA, INC. Common Stock, Value, Issued
SILO PHARMA, INC. (SILO) had Common Stock, Value, Issued of $113 as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-13
- 2026-06-30: Common Stock, Value, Issued $113.00.
- 2026-03-31: Common Stock, Value, Issued $1.63K.
- 2025-12-31: Common Stock, Value, Issued $89.00; Common Stock, Value, Issued as first filed $1.33K.
- 2025-09-30: Common Stock, Value, Issued $1.05K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $113.00 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $1.63K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $89.00 10-Q · filed 2026-08-13 | $1.33K 10-K · filed 2026-03-27 |
| 2025-09-30 | $1.05K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $865.00 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $449.00 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $449.00 POS AM · filed 2026-04-14 | |
| 2024-09-30 | $449.00 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $408.00 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $316.00 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $316.00 10-K · filed 2025-03-28 | |
| 2023-09-30 | $311.00 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $311.00 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $316.00 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $316.00 10-K · filed 2024-03-25 | |
| 2022-09-30 | $314.00 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $9.94K 10-Q · filed 2022-08-01 | |
| 2022-03-31 | $9.94K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $197.00 10-K · filed 2023-03-24 | $9.86K 10-K · filed 2022-03-28 |
| 2021-09-30 | $9.86K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $9.86K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $8.51K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $8.51K 10-K · filed 2022-03-28 | |
| 2020-09-30 | $8.51K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $8.31K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $2.36K 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $2.36K 10-K/A · filed 2021-05-17 | |
| 2019-09-30 | $2.35K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $2.35K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $2.34K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $2.34K 10-K · filed 2020-03-20 | |
| 2018-09-30 | $5.21K 10-Q · filed 2018-11-14 | |
| 2017-12-31 | $5.01K 10-K · filed 2019-04-04 | |
| 2013-12-31 | $4.06K 10-K · filed 2014-03-31 | |
| 2013-09-30 | $3.62K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $3.07K 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $3.07K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $3.06K 10-K · filed 2014-03-31 | |
| 2012-09-30 | $3.06K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $3.06K 10-Q · filed 2012-08-01 | |
| 2012-03-31 | $3.06K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $3.06K 10-K · filed 2013-03-05 | |
| 2011-09-30 | $3.06K 10-Q · filed 2011-11-10 | |
| 2011-06-30 | $3.06K 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $3.06K 10-K · filed 2012-01-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |